Abstract Accepted for Prestigious Meeting

Wednesday, July 13, 2005 Abstract Accepted for Prestigious Meeting Results of ongoing research into the efficacy of treating certain prostate cancers with combination therapy consisting of Palladium-103 brachytherapy (seed implant) and supplemental beam radiation, has been accepted for presentation at the annual meeting of the prestigious American Society of Therapeutic Radiation Oncology (ASTRO). The meeting will be held October 16-20, 2005 in Denver. Michael Dattoli, M...

Dual therapy

Dual therapy can control high-risk prostate cancer David Douglas Mon Aug 27, 2007 10:14pm EDT NEW YORK (Reuters Health) - High rates of tumor control over the long term are possible with combination treatment using external beam radiation followed by brachytherapy in high-risk prostate cancer patients, according to researchers. Health "These patients have been followed longer than any other treatment group reported in the prostate specific antigen era," lead ...

Purging Prostate Cancer

The latest technology at Dattoli Cancer Center & Brachytherapy Research Institute By: Virginia ‘Ginya’ Carnahan, APR, CPRC Michael Dattoli, MD, and Richard Sorace, MD, PhD, have shared a challenge for more than two decades. The radiation oncologists have sought a better way to treat prostate cancer – a definitive treatment that will defeat the cancer while not destroying the man’s quality of life after treatment. The reported incidence (and additional wh...

A doctor's cancer journey

It cost him $100,000 -- but it saved his life April 07, 2008 Denise Davy The Hamilton Spectator BURLINGTON (Apr 7, 2008) When a Burlington doctor discovered he had prostate cancer, he went in search of the best medical care money could buy. It took him to the United States and cost him $100,000, but balanced against his chances of survival if he'd stayed in Canada, it was an easy decision. Dr. Tom Johnson, 54, works at Halton Family Health Care and was healthy ...

Tools for fighting prostate cancer

Experience and knowledge are tools for fighting prostate cancer Published: Thursday, June 19, 2008 at 2:31 a.m. Regarding Sunday's front-page article, "As prostate drug gets new look, it stirs new debate": I'd like to comment. Having spent more than 25 years studying prostate cancer, and treating more than 10,000 men, I am well aware of the dilemmas presented by new drugs (such as finasteride -- Proscar) and treatment options (such as high-intensity focused ultraso...